These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36719360)

  • 21. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention.
    Oware K; Adiema L; Rono B; Violette LR; McClelland RS; Donnell D; Scoville CW; Odoyo J; Baeten JM; Bukusi E; Stewart J
    BMC Womens Health; 2023 Jun; 23(1):296. PubMed ID: 37270546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-exposure prophylaxis: an underutilized biomedical HIV prevention method among gay, bisexual and other men who have sex with men in China.
    Hou J; Wu Y; Xie L; Meng S; Fu R; Zheng H; He N; Huang X; Xu J; Meyers K
    AIDS Care; 2020 Dec; 32(12):1573-1580. PubMed ID: 32188267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling the potential impact of pre-exposure prophylaxis for HIV among men who have sex with men in Cameroon.
    Lyons CE; Stokes-Cawley OJ; Simkin A; Bowring AL; Mfochive Njindam I; Njoya O; Bissek AZ; Tamoufe U; Georges S; Kakanou FZ; Turpin G; Levitt D; Billong SC; Mishra S; Baral S
    BMC Infect Dis; 2022 Sep; 22(1):751. PubMed ID: 36163000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transmitted antiretroviral drug resistance in individuals with newly diagnosed HIV infection: South Carolina 2005-2009.
    Youmans E; Tripathi A; Albrecht H; Gibson JJ; Duffus WA
    South Med J; 2011 Feb; 104(2):95-101. PubMed ID: 21206421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017.
    Sullivan PS; Sanchez TH; Zlotorzynska M; Chandler CJ; Sineath RC; Kahle E; Tregear S
    J Int AIDS Soc; 2020 Mar; 23(3):e25461. PubMed ID: 32153119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States.
    Reisner SL; Moore CS; Asquith A; Pardee DJ; Sarvet A; Mayer G; Mayer KH
    J Int AIDS Soc; 2019 Sep; 22(9):e25391. PubMed ID: 31536171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population-Level Effectiveness of HIV Pre-exposure Prophylaxis Among MSM and Transgender Persons With Bacterial Sexually Transmitted Infections.
    Pagkas-Bather J; Khosropour CM; Golden MR; Thibault C; Dombrowski JC
    J Acquir Immune Defic Syndr; 2021 Jun; 87(2):769-775. PubMed ID: 33538527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is HIV Pre-Exposure Prophylaxis among Men Who Have Sex with Men Effective in a Real-World Setting? Experience with One-On-One Counseling and Support in a Sexual Health Center in Paris, 2018-2020.
    Thomas B; Piron P; de La Rochebrochard E; Segouin C; Troude P
    Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knowledge of and willingness to take pre-exposure prophylaxis among men who have sex with men in Israel.
    Zohar M; Guy S; Itzchak L
    Isr J Health Policy Res; 2021 Dec; 10(1):71. PubMed ID: 34872598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of HIV-1 molecular epidemiology and transmitted drug-resistance in newly diagnosed HIV-infected patients in Sichuan, China.
    Zhou C; Liang S; Li Y; Zhang Y; Li L; Ye L; Yuan D; Su L
    BMC Infect Dis; 2022 Jul; 22(1):602. PubMed ID: 35799101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping review.
    Elliott T; Sanders EJ; Doherty M; Ndung'u T; Cohen M; Patel P; Cairns G; Rutstein SE; Ananworanich J; Brown C; Fidler S
    J Int AIDS Soc; 2019 Dec; 22(12):e25419. PubMed ID: 31850686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China.
    Wang Z; Zhang M; Zhang R; Liu L; Shen Y; Wang J; Lu H
    BMC Infect Dis; 2019 Apr; 19(1):313. PubMed ID: 30961560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis.
    Dolling DI; Desai M; McOwan A; Gilson R; Clarke A; Fisher M; Schembri G; Sullivan AK; Mackie N; Reeves I; Portman M; Saunders J; Fox J; Bayley J; Brady M; Bowman C; Lacey CJ; Taylor S; White D; Antonucci S; Gafos M; McCormack S; Gill ON; Dunn DT; Nardone A;
    Trials; 2016 Mar; 17():163. PubMed ID: 27013513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study.
    Hanum N; Cambiano V; Sewell J; Phillips AN; Rodger AJ; Speakman A; Nwokolo N; Asboe D; Gilson R; Clarke A; Miltz AR; Collins S; Lampe FC;
    Lancet Public Health; 2020 Sep; 5(9):e501-e511. PubMed ID: 32888443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rising rates of recent preexposure prophylaxis exposure among men having sex with men newly diagnosed with HIV: antiviral resistance patterns and treatment outcomes.
    Girometti N; McCormack S; Tittle V; McOwan A; Whitlock G;
    AIDS; 2022 Mar; 36(4):561-566. PubMed ID: 34873084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introducing pre-exposure prophylaxis to prevent HIV acquisition among men who have sex with men in Sweden: insights from a mathematical pair formation model.
    Hansson D; Strömdahl S; Leung KY; Britton T
    BMJ Open; 2020 Feb; 10(2):e033852. PubMed ID: 32029492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and Demographic Characteristics of HIV Post-Exposure Prophylaxis Users in New York City.
    Adan MA; Zucker J; Carnevale C; Grant WL; Cohall AT; Gordon P; Olender SA; Sobieszczyk ME
    J Health Care Poor Underserved; 2020; 31(2):672-681. PubMed ID: 33410801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-level effectiveness of pre-exposure prophylaxis for HIV prevention among men who have sex with men in Montréal (Canada): a modelling study of surveillance and survey data.
    Doyle CM; Milwid RM; Cox J; Xia Y; Lambert G; Tremblay C; Otis J; Boily MC; Baril JG; Thomas R; Blais AD; Trottier B; Grace D; Moore DM; Mishra S; Maheu-Giroux M
    J Int AIDS Soc; 2023 Dec; 26(12):e26194. PubMed ID: 38054579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany.
    Jansen K; Steffen G; Potthoff A; Schuppe AK; Beer D; Jessen H; Scholten S; Spornraft-Ragaller P; Bremer V; Tiemann C;
    BMC Infect Dis; 2020 Feb; 20(1):110. PubMed ID: 32033533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel Online-to-Offline (O2O) model for pre-exposure prophylaxis and HIV testing scale up.
    Anand T; Nitpolprasert C; Trachunthong D; Kerr SJ; Janyam S; Linjongrat D; Hightow-Weidman LB; Phanuphak P; Ananworanich J; Phanuphak N
    J Int AIDS Soc; 2017 Mar; 20(1):21326. PubMed ID: 28362062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.